Cargando…
Midlife Plasma Aβ and Late-Life Risk of Cognitive Impairment: The Atherosclerosis Risk in Communities Study
Plasma-based biomarkers of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease, show promise in predicting cognitive impairment and mapping onto cerebral amyloidosis, but little is known about how midlife plasma Aβ associates with late-life cognitive outcomes. Midlife plasma varia...
Autores principales: | Sullivan, Kevin, Blackshear, Chad, Sharrett, A Richey, Gottesman, Rebecca, Knopman, David, Windham, B Gwen, Griswold, Michael, Mosley, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740202/ http://dx.doi.org/10.1093/geroni/igaa057.810 |
Ejemplares similares
-
Midlife and Late‐Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Power, Melinda C., et al.
Publicado: (2017) -
Regional Microstructural Integrity in Relation to Gait Speed: The Atherosclerosis Risk in Communities Study
por: Sullivan, Kevin, et al.
Publicado: (2021) -
Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Knopman, David S., et al.
Publicado: (2016) -
Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study
por: Bressler, J, et al.
Publicado: (2017) -
Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
por: Schneider, Andrea L.C., et al.
Publicado: (2017)